Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment

References

• Ahmadi, M., Abdolmohammadi-Vahid, S., Ghaebi, M., Aghebati-Maleki, L., Afkham, A., Danaii, S., et al. (2017) Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL). Biomed Pharmacother 92:1095-1102.
   Web of Science ®Google Scholar
• Allahbadia, G.N. and Allahbadia, S.G. (2003) Low Molecular Weight Heparin in Immunological Recurrent Abortion—The Incredible Cure. J Assist Reprod Genet 20(2):82–90.
   PubMed Web of Science ®Google Scholar
• Aluvihare, V.R., Kallikourdis, M. and Betz, A.G. (2004) Regulatory T cells mediate maternal tolerance to the fetus. Nature Immunol 5(3):266–271.
   PubMed Web of Science ®Google Scholar
• Ballow, M. (2002) Intravenous immunoglobulins: clinical experience and viral safety. J Am Pharm Assoc 42(3):449–459.
   Google Scholar
• Ballow, M. (2011) The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol 127(2):315–323.
   PubMed Web of Science ®Google Scholar
• Ballow, M. (2014) Mechanisms of immune regulation by IVIG. Curr Opin Allergy Clin Immunol 14(6):509–515.
   PubMed Web of Science ®Google Scholar
• Beer, A. and Kwak, J. (1997) Intravenous immunoglobulin G (IVIG): dream or reality. ART Symposium, Maui, Hawaii.
   Google Scholar
• Chaouat, G. (2016) Reconsidering the Medawar paradigm placental viviparity existed for eons, even in vertebrates; without a “problem”: Why are Tregs important for preeclampsia in great apes? J Reprod Immunol 114:48–57.
   Google Scholar
• Chatterjee, P., Chiasson, V.L., Bounds, K.R. and Mitchell, B.M. (2015) Regulation of the anti-inflammatory cytokines interleukin-4 and interleukin-10 during pregnancy. Front Immunol 5(253):124.
   Google Scholar
• Clark, D.A. (2008) Immunological factors in pregnancy wastage: fact or fiction. Am J Reprod Immunol 59(4):277–300.
   PubMed Web of Science ®Google Scholar
• Clark, D.A., Wong, K., Banwatt, D., Chen, Z., Liu, J., Lee, L., et al. (2008) CD200-dependent and nonCD200-dependant pathways of NK cell suppression by human IVIG. J Assist Reprod Genet 25(2–3):67–72.
   PubMed Web of Science ®Google Scholar
• Cooper, T.G., Noonan, E., Von Eckardstein, S., Auger, J., Baker, H., Behre, H.M., et al. (2010) World Health Organization reference values for human semen characteristics. Hum Reprod Update 16(3):231–245.
   PubMed Web of Science ®Google Scholar
• Coulam, C., Krysa, L. and Bustillo, M. (1994) Immunology: Intravenous immunoglobulin for in-vitro fertilization failure. Hum Reprod 9(12):2265–2269.
   PubMed Web of Science ®Google Scholar
• De Jong, P.G., Kaandorp, S., Di Nisio, M., Goddijn, M. and Middeldorp, S. (2014) Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia.Cochrane Database Syst Rev 2014 7: CD004734.
   Google Scholar
• Elram, T., Simon, A., Israel, S., Revel, A., Shveiky, D. and Laufer, N. (2005) Treatment of recurrent IVF failure and human leukocyte antigen similarity by intravenous immunoglobulin. Reprod Biomed Online 11(6):745–749.
   PubMed Web of Science ®Google Scholar
• Hanna, J., Goldman-Wohl, D., Hamani, Y., Avraham, I., Greenfield, C., Natanson-Yaron, S., et al. (2006) Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 12(9):1065.
   PubMed Web of Science ®Google Scholar
• Hori, S., Nomura, T. and Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609):1057–1061.
   PubMed Web of Science ®Google Scholar
• Kim, D.J., Lee, S.K., Kim, J.Y., Na, B.J., Hur, S.E., Lee, M., et al. (2014) Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3+ regulatory T cells in pregnant women with recurrent pregnancy loss. Am J Reprod Immunol 71(5):441–450.
   PubMed Web of Science ®Google Scholar
• Kwak‐Kim, J., Yang, K.M. and Gilman‐Sachs, A. (2009) Recurrent pregnancy loss: a disease of inflammation and coagulation. J Obstet Gynaecol Res 35(4):609–622.
   PubMed Web of Science ®Google Scholar
• Lee, S., Kim, J., Hur, S., Kim, C., Na, B., Lee, M., et al. (2011) An imbalance in interleukin-17-producing T and Foxp3+ regulatory T cells in women with idiopathic recurrent pregnancy loss. Hum Reprod 26(11):2964–2971.
   PubMed Web of Science ®Google Scholar
• Lee, S.K., Kim, J.Y., Han, A.R., Hur, S.E., Kim, C.J., Kim, T.H., et al. (2016) Intravenous immunoglobulin G improves pregnancy outcome in women with recurrent pregnancy losses with cellular immune abnormalities. Am J Reprod Immunol 75(1):59–68.
   PubMed Web of Science ®Google Scholar
• Lee, S.K., Kim, J.Y., Lee, M., Gilman‐Sachs, A. and Kwak‐Kim, J. (2012) Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reprod Immunol 67(4):311–318.
   PubMed Web of Science ®Google Scholar
• Lee, S.Y., Jung, Y.O., Ryu, J.G., Kang, C.M., Kim, E.K., Son, H.J., et al. (2014) Intravenous Immunoglobulin Attenuates Experimental Autoimmune Arthritis by Inducing Reciprocal Regulation of Th17 and Treg Cells in an Interleukin‐10–Dependent Manner. Arthritis Rheum 66(7):1768–1778.
   Web of Science ®Google Scholar
• Li, J., Chen, Y., Liu, C., Hu, Y. and Li, L. (2013) Intravenous immunoglobulin treatment for repeated IVF/ICSI failure and unexplained infertility: a systematic review and a meta‐analysis. Am J Reprod Immunol 70(6):434–447.
   PubMed Web of Science ®Google Scholar
• Loubaki, L., Chabot, D. and Bazin, R. (2015) Involvement of the TNF-α/TGF-β/IDO axis in IVIg-induced immune tolerance. Cytokine 71(2):181–187.
   PubMed Web of Science ®Google Scholar
• Maddur, M.S., Othy, S., Hegde, P., Vani, J., Lacroix-Desmazes, S., Bayry, J., et al. (2010) Immunomodulation by intravenous immunoglobulin: role of regulatory T cells. J Clin Immunol 30(1):4–8.
   Google Scholar
• Maddur, M.S., Sharma, M., Hegde, P., Lacroix-Desmazes, S., Kaveri, S.V. and Bayry, J. (2013) Inhibitory effect of IVIG on IL-17 production by Th17 cells is independent of anti-IL-17 antibodies in the immunoglobulin preparations. J Clin Immunol 33(1):62–66.
   Google Scholar
• Maddur, M.S., Stephen-Victor, E., Das, M., Prakhar, P., Sharma, V.K., Singh, V., et al. (2017) Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy. J Neuroinflammation 14(1):58.
   PubMedGoogle Scholar
• Moffett-King, A. (2002) Natural killer cells and pregnancy. Nat Rev Immunol 2(9):656-663.
   Web of Science ®Google Scholar
• Moraru, M., Carbone, J., Alecsandru, D., Castillo‐Rama, M., García‐Segovia, A., Gil, J., et al. (2012) Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56+ cells. Am J Reprod Immunol 68(1):75–84.
   PubMed Web of Science ®Google Scholar
• Nakashima, A., Ito, M., Shima, T., Bac, N.D., Hidaka, T. and Saito, S. (2010) Accumulation of IL‐17‐Positive Cells in Decidua of Inevitable Abortion Cases. Am J Reprod Immunol 64(1):4–11.
   PubMed Web of Science ®Google Scholar
• Nelson, S.M. and Greer, I.A. (2008) The potential role of heparin in assisted conception. Hum Reprod Update 14(6):623–645.
   PubMed Web of Science ®Google Scholar
• Norwitz, E.R., Schust, D.J. and Fisher, S.J. (2001) Implantation and the survival of early pregnancy. N Engl J Med 345(19):1400–1408.
   PubMed Web of Science ®Google Scholar
• Quaranta, M., Erez, O., Mastrolia, S.A., Koifman, A., Leron, E., Eshkoli, T., et al. (2015) The physiologic and therapeutic role of heparin in implantation and placentation. PeerJ 3:e691.
   PubMed Web of Science ®Google Scholar
• Ruocco, M.G., Chaouat, G., Florez, L., Bensussan, A. and Klatzmann, D. (2014) Regulatory T-cells in pregnancy: historical perspective, state of the art, and burning questions. Front Immunol 5:389.
   PubMed Web of Science ®Google Scholar
• Scher, J. and Salazar, C. (2000) Clinical experience with IVIg Rx in patients with prior failed IVF pregnancies: report of 30 consecutive patients. Am J Reprod Immunol 44(2):121–124.
   PubMed Web of Science ®Google Scholar
• Sher, G., Maassarani, G., Zouves, C., Feinman, M., Sohn, S., Matzner, W., et al. (1998) The use of combined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies. Am J Reprod Immunol 39(4):223–225.
   PubMed Web of Science ®Google Scholar
• Somerset, D.A., Zheng, Y., Kilby, M.D., Sansom, D.M. and Drayson, M.T. (2004) Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T‐cell subset. Immunology 112(1):38–43.
   PubMed Web of Science ®Google Scholar
• Sotnikova, N., Voronin, D., Antsiferova, Y. and Bukina, E. (2014) Interaction of decidual CD56+ NK with trophoblast cells during normal pregnancy and recurrent spontaneous abortion at early term of gestation. Scand J Immunol 80(3):198–208.
   PubMed Web of Science ®Google Scholar
• Tilburgs, T., Schonkeren, D., Eikmans, M., Nagtzaam, N.M., Datema, G., Swings, G.M., et al. (2010) Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties. J Immunol 185(7):4470–4477.
   PubMed Web of Science ®Google Scholar
• Trinath, J., Hegde, P., Sharma, M., Maddur, M.S., Rabin, M., Vallat, J.-M., et al. (2013) Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2–dependent prostaglandin E2 in human dendritic cells. Blood 122(8):1419–1427.
   PubMed Web of Science ®Google Scholar
• Van Egmond, A., Van Der Keur, C., Swings, G., Scherjon, S. and Claas, F. (2016) The possible role of virus-specific CD8+ memory T cells in decidual tissue. J Reprod Immunol 113:1–8.
   PubMed Web of Science ®Google Scholar
• Wang, W.-J., Hao, C.-F., Yin, G.-J., Bao, S.-H., Qiu, L.-H. and Lin, Q.-D. (2010) Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol 84(2):164–170.
   PubMed Web of Science ®Google Scholar
• Winger, E.E., Reed, J.L., Ashoush, S., Ahuja, S., El‐Toukhy, T. and Taranissi, M. (2009) Treatment with adalimumab (Humira®) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF. Am J Reprod Immunol 61(2):113–120.
   PubMed Web of Science ®Google Scholar
• Winger, E.E., Reed, J.L., Ashoush, S., El‐Toukhy, T., Ahuja, S. and Taranissi, M. (2011a) Elevated preconception CD56+ 16+ and/or Th1: Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF. Am J Reprod Immunol 66(5):394–403.
   PubMed Web of Science ®Google Scholar
• Winger, E.E., Reed, J.L., Ashoush, S., El‐Toukhy, T., Ahuja, S. and Taranissi, M. (2011b) Degree of TNF‐α/IL‐10 Cytokine Elevation Correlates With IVF Success Rates in Women Undergoing Treatment With Adalimumab (Humira) and IVIG. Am J Reprod Immunol 65(6):610–618.
   PubMed Web of Science ®Google Scholar
• Yamada, H., Morikawa, M., Kato, E.H., Shimada, S., Kobashi, G. and Minakami, H. (2003) Pre‐conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol 50(4):351–354.
   PubMed Web of Science ®Google Scholar
• Zinaman, M.J., Clegg, E.D., Brown, C.C., O’Connor, J. and Selevan, S.G. (1996) Estimates of human fertility and pregnancy loss. Fertil Steril 65(3):503–509.
   PubMed Web of Science ®Google Scholar